Marie Tatt wrote a letter to Elias Greene (and others) about the product licence application for Koate HS and requested that the existing "Warnings" statement (used in US markets) be amended for the UK. She wrote: "we would like to delete the reference to the Fletcher paper and potential transmission of Non-A, Non-B hepatitis".

Chronology Information

Date:

Chapter/issue
Pharmaceutical Companies
Key Person(s)
Elias L Greene
Marie Tatt